E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 6/30/2005 in the Prospect News Biotech Daily.

Allergan initiated by Leerink Swann at market perform

Allergan Inc. was initiated by Leerink Swann & Co. at a market perform rating. Based in Irvine, Calif., Allergan, maker of Botox, provides products for the eye care, neuromuscular, skin care and other specialty markets. Allergan shares on Thursday lost $1.13, or 1.31%, to close at $85.36 on volume of 750,200 shares versus the three-month running average of 1.18 million.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.